Physician's Weekly

JUNE 18, 2025

WEDNESDAY, June 18, 2025 (HealthDay News) — The Dietary Approaches to Stop Hypertension for Diabetes (DASH4D) diet with lower sodium is tied to clinically meaningful blood pressure reduction in people with diabetes, according to a study published online June 9 in JAMA Internal Medicine. Pilla, M.D., Pilla, M.D.,

Diabetes 71

Diabetes Internal Medicine Hypertension Clinic 71

Physician's Weekly

JUNE 11, 2025

WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration has approved Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults. “I am very excited and pleased to have Widaplik approved for the treatment of hypertension in the U.S. All rights reserved.

Hypertension 52

Hypertension Diabetes Patients Medical 52

Physician's Weekly

JUNE 22, 2025

The number of patients with heart failure is expected to rise sharply owing to ageing populations, poor dietary habits, unhealthy lifestyles and improved survival rates from conditions such as hypertension and myocardial infarction. Springer Nature Limited. first appeared on Physician's Weekly.

Hypertension 52

Hypertension Diabetes Individual Patients 52

Permanente Medicine

JUNE 10, 2025

June 10, 2025) — Maria Ansari, MD, FACC , co-CEO of The Permanente Federation at Kaiser Permanente, has been named to Modern Healthcare’s list of 50 Most Influential Clinical Executives for 2025. Improving access in adult and family medicine at TPMG by reducing appointment booking times by more than 33%.

Clinic 59

Clinic Patient-Centered Healthcare Medical 59

Physician's Weekly

JUNE 21, 2025

Lower education levels were linked to higher risk (OR = 0.82, P = 0.0001), along with smoking (OR = 1.44, P = 0.003), hypertension (OR = 2.25, P < 0.001), and cardiovascular disease (CVD) (OR = 2.61, P < 0.001). Source: frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1617248/full

Diabetes 52

Diabetes Hypertension Education Individual 52

Today's Hospitalist

JUNE 7, 2025

THE BLOCKBUSTER GLP-1 receptor agonists are a transformative class of medications increasingly tied to better outcomes across a variety of conditions and organ systems, not just in patients with obesity and type 2 diabetes. They presented a rapid clinical update Webinar in May 2025 hosted by the Society of Hospital Medicine.

Hospital 66

Hospital Management Diabetes Patients 66

GeriPal

JANUARY 16, 2025

So you mentioned the burden of chronic multimorbidity and sort of flogging through the diabetes and the hypertension. Yael 44:20 I would say for AGS 2025, because I’m going to be giving a presentation with a colleague about that specific issue. ABIM MOC credit will be offered to subscribers in November, 2025.

Patient-Centered 110

Patient-Centered IT Patients Healthcare 110